Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures. (16th February 2017)
- Record Type:
- Journal Article
- Title:
- Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures. (16th February 2017)
- Main Title:
- Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures
- Authors:
- Fu, Lu
Sun, Yao
Guo, Yongqing
Chen, Yan
Yu, Bin
Zhang, Haihong
Wu, Jiaxin
Yu, Xianghui
Kong, Wei
Wu, Hui - Abstract:
- Abstract : The abnormal deposition of amyloid‐ β (A β ) peptides in the brain is the main neuropathological hallmark of Alzheimer's disease (AD). Amyloid deposits are formed by a heterogeneous mixture of A β peptides, among which the most studied are A β 40 and A β 42. A β 40 is abundantly produced in the human brain, but the level of A β 42 is remarkably increased in the brain of AD patients. Aside from A β 40 and A β 42, recent data have raised the possibility that A β 43 peptides may be instrumental in AD pathogenesis. Besides its length, whether the A β aggregated form accounts for the neurotoxicity is also particularly controversial. A β fibrils are generally considered as key pathogenic substances in AD pathogenesis. Nevertheless, recent data implicated soluble A β oligomers as the main cause of synaptic dysfunction and memory loss in AD. To further address this uncertainty, we analyzed the neurotoxicity of different A β species and A β forms at the cellular level. The results showed that A β 42 could form oligomers significantly faster than A β 40 and A β 43 and A β 42 oligomers showed the greatest level of neurotoxicity. Regardless of the length of A β peptides, A β oligomers induced significantly higher cytotoxicity compared with the other two A β forms. Surprisingly, the neurotoxicity of fibrils in PC12 cells was only marginally but not significantly stronger than monomers, contrary to previous reports. Altogether, our findings demonstrate the high pathogenicity ofAbstract : The abnormal deposition of amyloid‐ β (A β ) peptides in the brain is the main neuropathological hallmark of Alzheimer's disease (AD). Amyloid deposits are formed by a heterogeneous mixture of A β peptides, among which the most studied are A β 40 and A β 42. A β 40 is abundantly produced in the human brain, but the level of A β 42 is remarkably increased in the brain of AD patients. Aside from A β 40 and A β 42, recent data have raised the possibility that A β 43 peptides may be instrumental in AD pathogenesis. Besides its length, whether the A β aggregated form accounts for the neurotoxicity is also particularly controversial. A β fibrils are generally considered as key pathogenic substances in AD pathogenesis. Nevertheless, recent data implicated soluble A β oligomers as the main cause of synaptic dysfunction and memory loss in AD. To further address this uncertainty, we analyzed the neurotoxicity of different A β species and A β forms at the cellular level. The results showed that A β 42 could form oligomers significantly faster than A β 40 and A β 43 and A β 42 oligomers showed the greatest level of neurotoxicity. Regardless of the length of A β peptides, A β oligomers induced significantly higher cytotoxicity compared with the other two A β forms. Surprisingly, the neurotoxicity of fibrils in PC12 cells was only marginally but not significantly stronger than monomers, contrary to previous reports. Altogether, our findings demonstrate the high pathogenicity of A β 42 among the three A β species and support the idea that A β 42 oligomers contribute to the pathological events leading to neurodegeneration in AD. Copyright © 2017 European Peptide Society and John Wiley & Sons, Ltd. Abstract : Neurotoxicity detection of different A β species (A β 40, A β 42 and A β 43 peptides) and different A β forms (monomers, oligomers and fibrils) at the cellular level. A β 42 exhibited the strongest ability to form oligomers or fibrils among the three A β species, and A β 42 oligomers induced a remarkably higher cytotoxicity compared with the other two A β forms. … (more)
- Is Part Of:
- Journal of peptide science. Volume 23:Number 3(2017)
- Journal:
- Journal of peptide science
- Issue:
- Volume 23:Number 3(2017)
- Issue Display:
- Volume 23, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 23
- Issue:
- 3
- Issue Sort Value:
- 2017-0023-0003-0000
- Page Start:
- 245
- Page End:
- 251
- Publication Date:
- 2017-02-16
- Subjects:
- Alzheimer's disease -- Aβ40 -- Aβ42 -- Aβ43 -- oligomer -- fibrils -- neurotoxicity
Peptides -- Periodicals
Peptides -- Periodicals
572.65 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/psc.2975 ↗
- Languages:
- English
- ISSNs:
- 1075-2617
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5030.530000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 484.xml